Skin Cancer Virtual Issue
British Association of Dermatologists 102nd Annual Meeting – 5th-7th July 2022

Read the collection of articles on skin cancer from all the three British Association of Dermatologists' journals and consider contributing to Skin Health and Disease’s upcoming Special Issue on skin cancer, as introduced by Dr. George Millington. 


British Journal of Dermatology 

Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration
I. Cosgarea, A.T. McConnell, T. Ewen, D. Tang, D.S. Hill, M. Anagnostou, M. Elias, R.A. Ellis, A. Murray, L.C. Spender, P. Giglio, M. Gagliardi, A. Greenwood, M. Piacentini, G.J. Inman, G.M. Fimia, M. Corazzari, J.L. Armstrong, P.E. Lovat

Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data
Z.C. Venables, S. Tokez, L.M. Hollestein, A.L. Mooyaart, R.R. van den Bos, B. Rous, I. M. Leigh, T. Nijsten, M. Wakkee

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020
S.G. Keohane, J. Botting, P.G. Budny, O.M. Dolan, K. Fife, C.A. Harwood, R. Mallipeddi, J.R. Marsden, R.J. Motley, C. Newlands, C. Proby, A. Rembielak, D.N. Slater, J.A. Smithson, P. Buckley, P. Fairbrother, M. Hashme, M.F. Mohd Mustapa, L.S. Exton, the British Association of Dermatologists’ Clinical Standards Unit

The effect of screening on melanoma incidence and biopsy rates
D.C. Whiteman, C.M. Olsen, S. MacGregor, M.H. Law, B. Thompson, J.C. Dusingize, A.C. Green, R.E. Neale, N. Pandeya, The QSkin Study


Clinical and Experimental Dermatology 

Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic
T. W. Andrew, M. Alrawi, P. Lovat

Costs of routine skin cancer screening in Germany: a claims data analysis
M. Krensel, V. Andrees, N. Mohr, S. Hischke

Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization
C. Baker, A. James, M. Supranowicz, L. Spelman, S. Shumack, J. Cole, W. Weightman, R. Sinclair, P. Foley

Descriptive analysis of 179 German reports of melanoma reported to an adverse drug reaction database as a drug-related adverse effect, and comparison with melanoma cases contained in German cancer registries
B. Sachs, D. Dubrall, K. Kraywinkel, M. Schulz, M. Schmid, J. Bate, W. Fischer-Barth


Skin Health and Disease 

An updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013–2018
M. Kwiatkowska, S. Ahmed, M. Ardern-Jones, L. A. Bhatti, T. O. Bleiker, A. Gavin, S. Hussain, D. W. Huws, L. Irvine, S. M. Langan, G. W. M. Millington, H. Mitchell, R. Murphy, L. Paley, C. M. Proby, C. S. Thomson, R. Thomas, C. Turner, S. Vernon, Z. C. Venables

The risk of subsequent invasive melanoma after a primary in situ or invasive melanoma in a high incidence country (New Zealand)
T.T. Win Myint, V. Selak, M. Elwood

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma
M. K. Ramirez-Fort, B. Meier-Schiesser, K. Lachance, S. S. Mahase, C. D. Church, M. J. Niaz, H. Liu, V. Navarro, A. Nikolopoulou, D. V. Kazakov, E. Contassot, D. P. Nguyen, J. Sach, L. Hadravsky, Y. Sheng, S. T. Tagawa, X. Wu, C. S. Lange, L. E. French, P. T. Nghiem, N. H. Bander

Skin cancers in skin types IV–VI: Does the Fitzpatrick scale give a false sense of security?
P. Goon, C. Banfield, O. Bello, N. J. Levell